Shutterstock
By André O. Hudson, Fidelma Fitzpatrick, Juliana Côrrea, Lori L. Burrows, Raúl Rivas González, Roy Robins-Browne, Yori Yuliandra
Monday, October 16, 2023 9:10 AM UTC
Almost since antibiotics were first discovered, we’ve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance.
The World Health Organization says we’re currently losing to the bugs, with resistance increasing and too few new antibiotics in the pipeline.
We wanted to know whether experts around the world think we will still have effective antibiotics in 50 years. Seven out of seven experts said yes.
Sign up for daily updates for the most important
stories unfolding in the global economy.
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
